A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions
about
API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysisThe paracaspase MALT1: biological function and potential for therapeutic inhibitionCrystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase regionAlternative splicing of MALT1 controls signalling and activation of CD4(+) T cellsAuto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase CNon-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2.The CBM signalosome: potential therapeutic target for aggressive lymphoma?Oncogenic activation of NF-kappaB.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.Molecular basis of lysophosphatidic acid-induced NF-κB activationCleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationInhibiting NF-κB activation by small molecules as a therapeutic strategy.MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interfaceThe E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.IAP-targeted therapies for cancer.Poxviral protein A52 stimulates p38 mitogen-activated protein kinase (MAPK) activation by causing tumor necrosis factor receptor-associated factor 6 (TRAF6) self-association leading to transforming growth factor β-activated kinase 1 (TAK1) recruitmeMalt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?Regulation of NF-κB signaling by caspases and MALT1 paracaspase.MALT lymphoma: many roads lead to nuclear factor-κb activation.MALT1 protease: a new therapeutic target in B lymphoma and beyond?Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.Roles of the NF-κB Pathway in B-Lymphocyte Biology.TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesisNF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex
P2860
Q26765188-DB9F53E5-215D-4117-B293-047AD8C0F5C3Q26778357-B28AEB2E-BE95-419A-84A0-8B3C4CEFA65FQ27676124-DA826D92-3018-4413-BE90-5F5EAD398E3AQ30385214-7EAE6366-6B03-4700-816A-5E7E4EC48B1BQ33417259-6CEE9FF0-66F6-4682-B139-CFBB8F622C64Q33530203-2C506F4B-BF8A-4F68-ABBA-A628F9BF339CQ33737597-536FC91C-FFEE-4913-A80A-322A1073109EQ33840233-69B78BF6-F486-4EAE-9DF6-193EC387FDB1Q33849388-B9907054-DE15-425F-91D7-A07AB273B69EQ33889168-EF0EE79B-FE23-44B3-9C48-A91C15BF117FQ34080225-E1B4F072-73F6-40B2-9B8F-8E5A15C93181Q34126537-C76D0878-9C92-4ADE-9E92-46FC08817F1AQ34161140-AA6FFDF2-C08E-4C2F-88A1-F7C9017132B7Q34205025-5A68A3D0-05DE-4A64-A675-36D3140B51E7Q34432953-A0B22BD2-A9A2-4B4C-BC67-FAA0BA8E6E8EQ34540475-ECAF7D9B-F415-428B-991E-DBDE73066D69Q34696221-322AAC49-EF07-4897-BB20-4F0F812BE12EQ34806889-3A5FF716-51F8-4531-81BE-00D2763E0174Q34973003-9EAA6D47-7C7F-42A5-839D-06CC1EF8A9A4Q35423381-5D1D8001-D513-4334-8725-E1108B028834Q36239551-A9B2082B-9605-49E0-B128-8D1300479EC2Q36406611-47CB264F-58A3-4303-933E-BFEE782CF756Q37302745-F8B0B1B2-C005-4B0F-9F98-8C0AB09CCB66Q37333716-516BFCDA-6180-48A9-9A52-433C59B499F7Q37397689-FBA42021-23C7-460B-B3AC-41FAC68131B0Q37814066-894CE43C-BAE4-4AF3-BAB5-C98196C8D5F1Q37831953-D69354F8-17EA-41B6-A16C-987B734E2ED0Q37922477-556FAE6B-3EBC-4810-8DA5-C9A444F590A8Q37944372-00106186-7FB3-4989-A08D-23D6B4767BDDQ38182355-2E5C83DA-DF9A-465C-95A1-13774ADF4573Q38495157-A2CDD67B-8E23-44A1-8E3C-684FDF2DE73FQ38567094-20D89EAE-5D44-4612-8230-655DEEC67DF4Q39880938-BE202764-1718-485E-8B9F-680708CFAEA3Q39927741-230279A1-7062-4715-924C-90E92596CB95Q54247368-B95115E8-9D56-41C4-B33D-D93D61222346Q54976736-72E6288D-924C-41B5-90B0-DCC89304D794Q57072726-30127E85-21F6-4079-872C-F5E86D2302DE
P2860
A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@ast
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@en
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@nl
type
label
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@ast
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@en
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@nl
prefLabel
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@ast
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@en
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@nl
P2093
P2860
P3181
P356
P1476
A Novel TRAF6 binding site in ...... by API2middle dotMALT1 fusions
@en
P2093
Geert van Loo
Heidi Noels
Mathijs Baens
Peter Marynen
Sofie Hagens
Vicky Broeckx
P2860
P304
P3181
P356
10.1074/JBC.M611038200
P407
P50
P577
2007-04-06T00:00:00Z